###begin article-title 0
Inhibition of GSK3 Phosphorylation of beta-Catenin via Phosphorylated PPPSPXS Motifs of Wnt Coreceptor LRP6
###end article-title 0
###begin p 1
Conceived and designed the experiments: GW XH. Performed the experiments: GW HH JGA. Analyzed the data: GW HH JGA XH. Contributed reagents/materials/analysis tools: XH. Wrote the paper: GW XH.
###end p 1
###begin p 2
Current address: School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China
###end p 2
###begin p 3
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 1381 1388 <span type="species:ncbi:8355">Xenopus</span>
The Wnt/beta-catenin signaling pathway plays essential roles in cell proliferation and differentiation, and deregulated beta-catenin protein levels lead to many types of human cancers. On activation by Wnt, the Wnt co-receptor LDL receptor related protein 6 (LRP6) is phosphorylated at multiple conserved intracellular PPPSPXS motifs by glycogen synthase kinase 3 (GSK3) and casein kinase 1 (CK1), resulting in recruitment of the scaffolding protein Axin to LRP6. As a result, beta-catenin phosphorylation by GSK3 is inhibited and beta-catenin protein is stabilized. However, how LRP6 phosphorylation and the ensuing LRP6-Axin interaction lead to the inhibition of beta-catenin phosphorylation by GSK3 is not fully understood. In this study, we reconstituted Axin-dependent beta-catenin phosphorylation by GSK3 and CK1 in vitro using recombinant proteins, and found that the phosphorylated PPPSPXS peptides directly inhibit beta-catenin phosphorylation by GSK3 in a sequence and phosphorylation-dependent manner. This inhibitory effect of phosphorylated PPPSPXS motifs is direct and specific for GSK3 phosphorylation of beta-catenin at Ser33/Ser37/Thr41 but not for CK1 phosphorylation of beta-catenin at Ser45, and is independent of Axin function. We also show that a phosphorylated PPPSPXS peptide is able to activate Wnt/beta-catenin signaling and to induce axis duplication in Xenopus embryos, presumably by inhibition of GSK3 in vivo. Based on these observations, we propose a working model that Axin recruitment to the phosphorylated LRP6 places GSK3 in the vicinity of multiple phosphorylated PPPSPXS motifs, which directly inhibit GSK3 phosphorylation of beta-catenin. This model provides a possible mechanism to account, in part, for inhibition of beta-catenin phosphorylation by Wnt-activated LRP6.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 170 180 167 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 215 222 212 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 280 283 277 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Logan1">[1]</xref>
###xml 284 287 281 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-vanEs1">[3]</xref>
###xml 615 618 606 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Polakis1">[4]</xref>
###xml 829 855 817 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adenomatous polyposis coli</italic>
###xml 918 921 903 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Liu1">[5]</xref>
###xml 922 926 907 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Wu1">[15]</xref>
###xml 1019 1023 998 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Winston1">[16]</xref>
###xml 1024 1028 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Wu3">[22]</xref>
###xml 1050 1059 1029 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-TrCP</sup>
###xml 1096 1105 1072 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-TrCP</sup>
###xml 1219 1223 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Aberle1">[23]</xref>
###xml 1225 1229 1192 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Orford1">[24]</xref>
###xml 1626 1630 1584 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Behrens2">[25]</xref>
###xml 1631 1635 1589 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Molenaar1">[27]</xref>
###xml 1728 1732 1683 1687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-He1">[28]</xref>
###xml 1734 1738 1689 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tetsu1">[29]</xref>
###xml 170 180 <span type="species:ncbi:7227">Drosophila</span>
###xml 215 222 <span type="species:ncbi:8355">Xenopus</span>
###xml 558 563 <span type="species:ncbi:9606">human</span>
The Wnt/beta-catenin signal transduction pathway plays central roles in many aspects of cell proliferation and differentiation, such as segment polarity determination in Drosophila, dorsal-ventral axis formation in Xenopus, and homeostasis of the mammalian gastrointestinal tract [1]-[3]. The onco-protein beta-catenin is a central component of the Wnt signaling pathway. Its protein level inside the cell is tightly regulated by phosphorylation-dependent and ubiquitin-mediated degradation, and deregulated beta-catenin protein level leads to many types of human cancers, such as colorectal carcinoma and melanoma [4]. In the absence of secreted Wnt ligands, cytosolic beta-catenin is phosphorylated at Ser45 by the priming kinase casein kinase 1 (CK1). Consequently, glycogen synthase kinase 3 (GSK3), in complex with Axin and adenomatous polyposis coli (APC), phosphorylates beta-catenin at Thr41, Ser37, and Ser33 [5]-[15]. Ser33 and Ser37 doubly-phosphorylated beta-catenin is specifically recognized by beta-TrCP [16]-[22], a subunit of the SCFbeta-TrCP E3 ubiquitin ligase complex. The SCFbeta-TrCP ubiquitin ligase poly-ubiquitinates beta-catenin, leading to beta-catenin degradation via the proteosome pathway [23], [24]. In the presence of Wnt ligands, the activation of the Wnt pathway results in inhibition of beta-catenin phosphorylation at Ser33 and Ser37 (and Thr41) by GSK3, thereby preventing beta-catenin ubiquitination and degradation. Stabilized beta-catenin translocates into the nucleus and complexes with members of the T cell factor (TCF)/lymphoid enhancer factor (LEF) family of transcription factors [25]-[27], leading to the activation of Wnt/beta-catenin responsive genes such as c-myc and cyclin D1 [28], [29]. Therefore, inhibition of amino-terminal phosphorylation of beta-catenin by GSK3 is a central step in Wnt/beta-catenin signaling.
###end p 5
###begin p 6
###xml 346 350 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai1">[30]</xref>
###xml 351 355 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-He2">[33]</xref>
###xml 510 514 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 516 520 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 597 601 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 603 607 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 702 706 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-He2">[33]</xref>
###xml 708 712 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Mao1">[36]</xref>
###xml 998 1002 989 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 1004 1008 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 1010 1014 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 1084 1088 1075 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 1090 1094 1081 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 1096 1100 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Davidson1">[38]</xref>
###xml 1185 1189 1176 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng3">[39]</xref>
###xml 1191 1195 1182 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Bilic1">[40]</xref>
Wnt activates the beta-catenin pathway via two distinct classes of receptors on the cell surface: one is a member of the Frizzled family of seven-transmembrane receptors, and the other is a single transmembrane receptor referred to as LDL receptor related protein 6 (LRP6), or its relative LRP5. Wnt may induce a Frizzled-LRP6 coreceptor complex [30]-[33], which in turn triggers the phosphorylation of LRP6 intracellular domain at five conserved PPP(S/T)PX(S/T) motifs (referred to as PPPSPXS for simplicity) [34], [35]. The phosphorylated PPPSPXS motif provides an optimal binding site for Axin [34], [35], thereby recruiting Axin and likely associated proteins to the Frizzled-LRP6 receptor complex [33], [36] and leading to the inhibition of beta-catenin phosphorylation. Importantly the phosphorylated PPPSPXS motif represents a key and minimal functional module of the Wnt receptor complex, since it is sufficient to trigger beta-catenin signaling when transferred to a heterologous receptor [34], [35], [37]. PPPSPXS phosphorylation is carried out sequentially by GSK3 and CK1 [35], [37], [38] and is under the control by Frizzled and its downstream partner Dishevelled protein [39], [40].
###end p 6
###begin p 7
###xml 1035 1041 1017 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1171 1175 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Cselenyi1">[41]</xref>
###xml 1310 1316 1289 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1424 1428 1400 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Cselenyi1">[41]</xref>
###xml 766 773 <span type="species:ncbi:8355">Xenopus</span>
How PPPSPXS phosphorylation and its recruitment of Axin result in inhibition of beta-catenin phosphorylation remains a critical question. To address this issue we established an in vitro beta-catenin phosphorylation system using recombinant Axin, GSK3 and CK1. We found that each of the multiple phosphorylated PPPSPXS peptides inhibits the phosphorylation of beta-catenin at Ser33/Ser37/Thr41 by GSK3 in a sequence and phosphorylation-dependent manner. This inhibition is specific for GSK3, as these phospho-peptides do not affect beta-catenin Ser45 phosphorylation by CK1, and occurs regardless of the presence or absence of Axin. We also found that a phosphorylated PPPSPXS peptide is able to activate Wnt/beta-catenin signaling and to induce axis duplication in Xenopus embryos, presumably via inhibition of GSK3 in vivo. These results suggest a potential mechanism to account, in part, for the inhibition GSK3 phosphorylation of beta-catenin by the activated LRP6. While this manuscript was in previous review processes, Cselenyi et al. reported that the LRP6 intracellular domain directly inhibits GSK3 phosphorylation of beta-catenin in a PPPSPXS-dependent manner [41]. Our results based on studying individual phospho-PPPSPXS peptides are consistent with their main conclusion. However, while Cselenyi et al. suggested that LRP6 specifically inhibits GSK3 phosphorylation of beta-catenin but not of other substrates [41], our data suggest that the phosphorylated PPPSPXS peptide behaves as a general GSK3 inhibitor.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Reconstitution of Axin-dependent beta-catenin amino-terminal phosphorylation by CK1 and GSK3 in vitro
###end title 9
###begin p 10
###xml 303 310 288 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 429 438 414 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g001">Figure 1A</xref>
###xml 540 541 522 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 303 310 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
To study how beta-catenin phosphorylation is regulated by upstream components of the Wnt pathway, we reconstituted an in vitro kinase assay for beta-catenin amino-terminal phosphorylation using purified proteins. We overexpressed recombinant beta-catenin, Axin, CK1beta, and GSK3beta proteins in either E. coli or baculovirus-infected insect cells, and purified these proteins to over 90% homogeneity by affinity chromatography (Figure 1A). We incubated purified beta-catenin with Axin, CK1, and GSK3 protein in the presence of ATP and MgCl2 at 37degreesC for 3 hours. beta-catenin phopshorylation was analyzed by immunoblotting using an antibody specific for Ser45-phosphorylation (by CK1) or an antibody specific for Ser33/Ser37/Thr41-phosphorylation (by GSK3).
###end p 10
###begin title 11
In vitro reconstitution of Axin-dependent and CK1 priming-dependent beta-catenin phosphorylation by GSK3.
###end title 11
###begin p 12
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 356 357 347 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 570 571 555 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
A. Recombinant GST-beta-catenin, Flag-CK1, MBP-Axin, and His-GSK3 proteins were expressed in bacteria or insect cells and purified by glutathione agarose, anti-Flag M2 agarose, amylose resin, or Ni-NTA resin, respectively. In the case of beta-catenin, GST was cleaved via thrombin and purified away from beta-catenin. * indicates each recombinant protein. B. beta-catenin phosphorylation by CK1 was reconstituted in vitro using purified proteins. The phosphorylation reaction products were analyzed by western blotting using an anti-phospho-Ser45 beta-catenin antibody. C. Axin-dependent phosphorylation by GSK3 was reconstituted in vitro using purified proteins. For Axin-dependent beta-catenin phosphorylation in this and other figures, 0.43 microM of GSK3, 0.54 microM of CK1alpha, 0.21 microM of Axin, and 0.73 microM of beta-catenin were used in each assay. The phosphorylation reaction products were analyzed by western blotting using an anti-phospho-Ser45 beta-catenin antibody and an anti-phospho-Ser33/Ser37/Thr41 beta-catenin antibody.
###end p 12
###begin p 13
###xml 96 105 93 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g001">Figure 1B</xref>
###xml 236 253 230 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g001">Figure 1C, lane 4</xref>
###xml 333 350 324 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g001">Figure 1C, lane 2</xref>
###xml 432 456 423 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g001">Figure 1C, lanes 3 and 5</xref>
###xml 511 515 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Dajani1">[42]</xref>
When CK1 was present in the kinase reaction, beta-catenin was strongly phosphorylated at Ser45 (Figure 1B). When CK1, Axin and GSK3 were all present in the kinase reaction, beta-catenin was potently phosphorylated at Ser33/Ser37/Thr41 (Figure 1C, lane 4). Phosphorylation of beta-catenin at Ser33/Ser37/Thr41 fully depended on GSK3 (Figure 1C, lane 2), and also required the presence of Axin and the priming phosphorylation by CK1 (Figure 1C, lanes 3 and 5). These results are consistent with an earlier report [42], and importantly, recapitulate the in vivo requirement of beta-catenin phosphorylation. Therefore we have reconstituted an in vitro kinase assay for Axin-dependent beta-catenin amino-terminal phosphorylation by CK1 and GSK3 using purified proteins.
###end p 13
###begin title 14
Design of phosphorylated PPPSPXS motif peptides
###end title 14
###begin p 15
###xml 95 99 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 101 105 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 336 345 330 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g002">Figure 2A</xref>
###xml 490 499 484 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g002">Figure 2B</xref>
###xml 677 681 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 683 687 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Wolf1">[43]</xref>
###xml 962 971 956 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g002">Figure 2B</xref>
###xml 1062 1066 1053 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
A single phosphorylated PPPSPXS motif is sufficient to activate beta-catenin signaling in vivo [34], [37]. In order to investigate whether these PPPSPXS motifs might regulate beta-catenin amino-terminal phosphorylation in our in vitro assay, we employed 4 phosphorylated PPPSPXS peptides corresponding to A, C, D, and E motifs of LRP6 (Figure 2A), referred to as Phos-A, Phos-C, Phos-D, and Phos-E, respectively, in which the two Ser/Thr residues in the PPPSPXS motifs were phosphorylated (Figure 2B). Although motif B behaves similarly to the other PPPSPXS motifs when tested in isolation in mammalian cells, motif B appears to be the least critical one in the wild type LRP6 [37], [43]. We therefore did not synthesize and test motif B. As controls, we also synthesized an HA peptide, a dually phosphorylated 14-3-3 binding peptide (14-3-3BP), and a mutant motif A peptide (A-mut), which harbors alanine replacement of the two phosphorylated Ser/Thr residues (Figure 2B) and which has been shown to be completely inactive in Wnt/beta-catenin signaling in vivo [35].
###end p 15
###begin title 16
###xml 50 55 <span type="species:ncbi:9606">human</span>
Peptide design according to the PPPSPXS motifs in human LRP6.
###end title 16
###begin p 17
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 493 497 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 499 503 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 52 57 <span type="species:ncbi:9606">human</span>
A. Sequence alignment of the five PPPSPXS motifs in human LRP6 and LRP5 by the Cluster V program. The PPPSPXS motifs are highlighted in color and boxed. B. The sequences of synthetic peptides are shown. The PPPSPXS motifs in the peptides are underlined, and phosphorylated Ser/Thr residues are shown in italics. The C or K residue in the parenthesis at the amino terminus of peptides A, C, D, and E was introduced for protein conjugation purposes (during immunization for antibody production) [34], [37].
###end p 17
###begin title 18
Phosphorylated PPPSPXS peptides inhibit beta-catenin Ser33/Ser37/Thr41 phosphorylation by GSK-3
###end title 18
###begin p 19
###xml 240 261 234 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3A, left panel</xref>
###xml 327 336 321 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g002">Figure 2B</xref>
###xml 404 425 395 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3A, left panel</xref>
###xml 530 534 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 602 624 590 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3A, right panel</xref>
###xml 784 800 769 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3B and 3C</xref>
###xml 994 1011 976 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3B, 3D, 3E</xref>
###xml 1060 1073 1042 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3D, 3E</xref>
###xml 1177 1194 1156 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3B, 3D, 3E</xref>
###xml 1348 1355 1327 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
When the phosphorylated PPPSPXS peptides were added to the in vitro beta-catenin phosphorylation assay, the Phos-A, Phos-C, as well as Phos-E peptide each inhibited, interestingly, beta-catenin phosphorylation at Ser33/Ser37/Thr41 by GSK3 (Figure 3A, left panel). The Phos-D peptide, which is atypical and has a CPPSPXS motif (Figure 2B), inhibited beta-catenin phosphorylation by GSK3 to a less degree (Figure 3A, left panel). We note that in cultured cells motif D also exhibits significant less activity than A, C and E motifs [37]. The A-mut peptide failed to inhibit beta-catenin phosphorylation (Figure 3A, right panel). As additional controls, neither the HA peptide nor the unrelated and dually phosphorylated peptide, 14-3-3BP, affected beta-catenin phosphorylation by GSK3 (Figure 3B and 3C). Furthermore, when the amount of peptides used in the phosphorylation assay was titrated, Phos-A, Phos-C and Phos-E peptides inhibited beta-catenin phosphorylation in a dose-dependent manner (Figure 3B, 3D, 3E), whereas Phos-D was significantly less active (Figure 3D, 3E). The HA and A-mut peptides did not inhibit beta-catenin phosphorylation at all concentrations tested (Figure 3B, 3D, 3E). We note that the molar concentrations of phospho-PPPSPXS peptides employed in these titration assays were 0.4x, 1.5x, 6x, and 24x of that of GSK3 (see Methods).
###end p 19
###begin title 20
Phosphorylated PPPSPXS peptides inhibit beta-catenin phosphorylation by GSK3 in vitro.
###end title 20
###begin p 21
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 228 229 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 349 350 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 469 470 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 607 608 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 753 762 734 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g001">Figure 1C</xref>
A. The HA, Phos-E, Phos-C, Phos-D and Phos-A peptides (left panel) and the HA, Phos-A, and A-mut peptides (right panel) were included in the beta-catenin phosphorylation assay. Each peptide was at 10 microM final concentration. B. Four-fold serial dilutions of HA, Phos-A, and A-mut peptides were included in the beta-catenin phosphorylation assay. C. Four-fold serial dilutions of Phos-A, and 14-3-3BP peptides were included in the beta-catenin phosphorylation assay. D. Four-fold serial dilutions of HA, Phos-E, Phos-A, Phos-C, and Phos-D peptides were included in the beta-catenin phosphorylation assay. E. The result from D was quantified via Adobe Photoshop. beta-catenin phosphorylation assays were performed in the presence of Axin and CK1 as in Figure 1C. Each peptide was at 10 microM, 2.5 microM, 0.63 microM, and 0.16 microM (four-fold serial dilutions) final concentration. The phosphorylation reaction products were analyzed by western blotting using an anti-phospho-Ser33/Ser37/Thr41 beta-catenin antibody and an anti-beta-catenin antibody.
###end p 21
###begin title 22
The phosphorylated PPPSPXS motif inhibits beta-catenin phosphorylation by GSK3 but not by CK1 via an Axin-independent manner
###end title 22
###begin p 23
###xml 132 136 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 138 142 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 144 148 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 399 415 389 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4A and 4B</xref>
###xml 491 495 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Mao1">[36]</xref>
###xml 880 889 859 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4C</xref>
###xml 1091 1107 1067 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4A and 4B</xref>
###xml 1230 1234 1200 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Dajani1">[42]</xref>
###xml 1472 1481 1439 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4D</xref>
Since Axin is a scaffolding protein critical for GSK3 phosphorylation of beta-catenin and binds to the phosphorylated PPPSPXS motif [34], [35], [37], we considered the possibility whether inhibition of beta-catenin phosphorylation by the phosphorylated PPPSPXP motif involves the binding between Axin and the phosphorylated PPPSPXS motif. To this end we first employed an Axin mutant, AxinDeltaDIX (Figure 4A and 4B), which lacks the so-called DIX domain required for Axin-binding to LRP5/6 [36] and therefore does not associate with phosphorylated LRP6 or the PPPSPXP motif (H. H and X. H., unpublished results). beta-catenin phosphorylation by GSK3 in vitro was promoted by AxinDeltaDIX as effectively as the wild type Axin; but unexpectedly, this reaction was inhibited by Phos-A in a similar dose-dependent manner in the presence of either the wild type Axin or AxinDeltaDIX (Figure 4C). This result implies that Phos-A inhibition of beta-catenin phosphorylation by GSK3 may not involve its binding to Axin. To address this issue further, we tested another Axin fragment, Axin(351-701) (Figure 4A and 4B), which contains only the beta-catenin- and GSK3-binding domains of Axin and promote beta-catenin phosphorylation by GSK3 [42]. Indeed beta-catenin phosphorylation by GSK3 was promoted by Axin(351-701) similarly to that by the wild type Axin, and importantly, was inhibited by Phos-A in a dose-dependent manner regardless of the presence of Axin or Axin(351-701) (Figure 4D). These results suggest that phosphorylated PPPSPXS peptide inhibited beta-catenin phosphorylation by GSK3 via a manner that is independent of PPPSPXS-binding to Axin, perhaps by inhibiting GSK3 directly.
###end p 23
###begin title 24
The inhibition of beta-catenin phosphorylation by phosphorylated PPPSPXS peptides is specific for GSK3 and independent of Axin function.
###end title 24
###begin p 25
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 141 142 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 380 381 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 386 387 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 606 614 591 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3</xref>
###xml 839 840 817 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1590 1591 1536 1537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
A. Different Axin constructs used in this study, the full length Axin (amino acid 1-863), AxinDeltaDix (1-773), and Axin(351-701) are shown. B. Purification of the full length Axin, AxinDeltaDix, and Axin(351-701) proteins. These Flagged tagged Axin and Axin fragments were expressed in HEK293T cells, purified via M2 agarose (Sigma) resin, and eluted by 0.2 mg/ml Flag peptides. C and D. The Phos-A peptide inhibited GSK3 phosphorylation of beta-catenin in the presence of the full length Axin, or AxinDeltaDIX (C), or Axin(351-701) (D). Four-fold serial dilutions of the Phos-A peptide were tested as in Figure 3. The A-mut peptide was added at the concentration equivalent to that of Phos-A without dilution (10 microM). The phosphorylation reaction products were analyzed using an anti-phospho-Ser33/Ser37/Thr41 beta-catenin antibody. E. Inhibition of GSK3 phosphorylation of beta-catenin by Phos-A was independent of Axin. Four-fold serial dilutions of the Phos-A peptide (10 microM, 2.5 microM, and 0.63 microM) were included in the beta-catenin phosphorylation assay in the absence or presence of Axin. The A-mut peptide was added at the concentration equivalent to that of Phos-A without dilution (10 microM). The phosphorylation reaction products were analyzed using an anti-phospho-Ser33/Ser37/Thr41 beta-catenin antibody. Note that in order to achieve and visualize beta-catenin phosphorylation by GSK3 in the absence of Axin (lanes 1-5), 5-fold excess amount of GSK3 (2.2 microM) was employed compared to that in the presence of Axin (lanes 6-10), and the film was overexposed. F. beta-catenin Ser45 phosphorylation by CK1 was not affected by Phos-A, used at 10 microM and 2.5 microM. A-mut was at 10 microM. The phosphorylation reaction products were analyzed using an anti-phospho-Ser33/Ser37/Thr41 beta-catenin antibody and an anti-phospho-Ser45 beta-catenin antibody.
###end p 25
###begin p 26
###xml 19 27 19 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g001">Figure 1</xref>
###xml 120 123 117 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Ikeda1">[9]</xref>
###xml 125 129 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Dajani1">[42]</xref>
###xml 248 251 242 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Liu1">[5]</xref>
###xml 253 256 247 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Ikeda1">[9]</xref>
###xml 258 262 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Dajani1">[42]</xref>
###xml 463 472 454 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4E</xref>
###xml 503 512 494 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3B</xref>
###xml 621 630 609 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4E</xref>
As demonstrated in Figure 1, beta-catenin phosphorylation by GSK3 in vitro was greatly enhanced by the presence of Axin [9], [42]. However, GSK3 can nonetheless phosphorylate beta-catenin in vitro, although less efficiently, in the absence of Axin [5], [9], [42]. Taking advantage of this property, we found that beta-catenin phosphorylation at Ser33/Ser37/Thr41 by GSK3 in the absence of Axin was also inhibited by the Phos-A peptide in a dose-dependent manner (Figure 4E). As in the presence of Axin (Figure 3B), the A-mut peptide had little or no effect on beta-catenin phosphorylation by GSK3 in the absence of Axin (Figure 4E). These results suggest that phosphorylated PPPSPXS motif directly inhibits GSK3 phosphorylation of beta-catenin.
###end p 26
###begin p 27
###xml 127 130 121 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Liu1">[5]</xref>
###xml 213 214 207 208 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 221 225 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 227 231 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Davidson1">[38]</xref>
###xml 527 536 512 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4F</xref>
###xml 662 671 644 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4F</xref>
CK1 phosphorylates beta-catenin at Ser45, which is the priming site for beta-catenin Ser33/Ser37/Thr41 phosphorylation by GSK3 [5]. In addition, CK1 also phosphorylates LRP6 at the second Ser residue in the PPPSPXS motif [35], [38]. Therefore we tested whether the dually phosphorylated PPPSPXS peptide had any effect on beta-catenin Ser45 phosphorylation by CK1. Although the Phos-A peptide inhibited beta-catenin phosphorylation at Ser33/Ser37/Thr41 by GSK3, it had no effect on beta-catenin phosphorylation at Ser45 by CK1 (Figure 4F). The A-mut peptide had little or no effect on beta-catenin phosphorylation at Ser33/Ser37/Thr41 by GSK3 or at Ser45 by CK1 (Figure 4F). These results together suggest that the dually phosphorylated PPPSPXS motif can inhibit beta-catenin phosphorylation at Ser33/Ser37/Thr41 by GSK3 independent of Axin, but it does not affect beta-catenin phosphorylation at Ser45 by CK1.
###end p 27
###begin title 28
The dually phosphorylated PPPSPXS peptide inhibits the phosphorylation of glycogen synthase and Tau by GSK3
###end title 28
###begin p 29
###xml 301 305 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Doble1">[44]</xref>
###xml 430 437 424 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 499 508 493 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g005">Figure 5A</xref>
###xml 639 643 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Doble1">[44]</xref>
###xml 675 676 669 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 762 786 756 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g005">Figure 5B, lanes 1 and 6</xref>
###xml 904 921 898 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g005">Figure 5B, lane 3</xref>
###xml 1122 1131 1116 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g005">Figure 5C</xref>
###xml 1238 1247 1232 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g005">Figure 5D</xref>
###xml 1355 1359 1349 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Greenberg1">[45]</xref>
###xml 1504 1513 1498 1507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g005">Figure 5E</xref>
###xml 1781 1797 1772 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g005">Figure 5F and 5G</xref>
###xml 324 329 <span type="species:ncbi:10090">mouse</span>
###xml 430 437 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Since the dually phosphorylated PPPSPXS peptide directly inhibited beta-catenin phosphorylation at Ser33/Ser37/Thr41 by GSK3 independent of Axin, we tested whether this inhibition was specific for beta-catenin or was broad for other GSK3 substrates, such as glycogen synthase (GS) and the Tau protein [44]. We expressed the mouse glycogen synthase carboxyl terminal domain (mGS-CTD, amino acid 585-738) as a GST-fusion protein in E. coli, and purified mGS-CTD by GST column affinity chromatography (Figure 5A). We reconstituted in vitro phosphorylation for mGS-CTD by incubating it together with GSK3 and the priming casein kinase 2 (CK2) [44] in the presence of ATP and MgCl2. When CK2 and GSK3 were both present, mGS-CTD was strongly phosphorylated at Ser641 (Figure 5B, lanes 1 and 6). When CK2 was absent from the reaction, the phosphorylation of mGS-CTD at Ser641 by GSK3 was significantly reduced (Figure 5B, lane 3), recapitulating CK2 priming phosphorylation-dependent GS phosphorylation by GSK3. We found that the Phos-A peptide, but not the A-mutant peptide, inhibited mGS-CTD phosphorylation by GSK3 at Ser641 (Figure 5C). GSK3 also phosphorylated purified Tau protein in vitro, which does not require priming phosphorylation (Figure 5D), as detected by the anti-phospho-Tau antibody PHF1 (specific for Tau phosphorylated at Ser396 and Ser404) [45]. When the Phos-A peptide was added to the in vitro assay, Tau phosphorylation was greatly reduced, whereas the A-mut peptide had little effect (Figure 5E). In addition, when Phos-A peptide was titrated in the phosphorylation assay performed side-by-side for Tau and beta-catenin (without Axin but with CK1 priming phosphorylation), indistinguishable dose-dependent inhibition of GSK3 by Phos-A was reproducibly observed (Figure 5F and 5G). These results suggest that the phosphorylated PPPSPXS motif inhibits GSK3 kinase activity towards multiple substrates.
###end p 29
###begin title 30
The phosphorylated PPPSPXS peptide inhibits phosphorylation of glycogen synthase and Tau by GSK3.
###end title 30
###begin p 31
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 315 316 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 484 485 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 638 639 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 796 797 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 802 803 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
A. Recombinant GST-tagged mouse glycogen synthase carboxyl-terminal domain (mGS-CTD) was expressed in bacteria, and purified by glutathione agarose resin. B. In vitro reconstitution of GS phosphorylation by CK2 and GSK3. The phosphorylation reaction products were analyzed using an anti-phospho-Ser641 GS antibody. C. GS phosphorylation at Ser641 was inhibited by Phos-A, but not by A-mut. The phosphorylation reaction products were analyzed using an anti-phospho-Ser641 GS antibody. D. In vitro reconstitution of Tau phosphorylation by GSK3. The phosphorylation reaction products were analyzed using an anti-phospho-Tau antibody (PHF1). E. Tau phosphorylation was inhibited by Phos-A, but not A-mut. The phosphorylation reaction products were analyzed using an anti-phospho-Tau antibody (PHF1). F and G. Different concentrations of Phos-A inhibited beta-catenin and Tau phosphorylation by GSK3 in a similar manner. A four-fold dilution of Phos-A was employed. The graph represents the average of three independent experiments.
###end p 31
###begin title 32
###xml 81 88 <span type="species:ncbi:8355">Xenopus</span>
The dually phosphorylated PPPSPXS peptide can activate beta-catenin signaling in Xenopus embryos
###end title 32
###begin p 33
###xml 375 379 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-He3">[46]</xref>
###xml 381 385 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Dominguez1">[47]</xref>
###xml 387 391 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Pierce1">[48]</xref>
###xml 606 610 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Harland1">[49]</xref>
###xml 612 620 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g006">Figure 6</xref>
###xml 742 750 730 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g006">Figure 6</xref>
###xml 359 366 <span type="species:ncbi:8355">Xenopus</span>
###xml 470 477 <span type="species:ncbi:8355">Xenopus</span>
###xml 1030 1037 <span type="species:ncbi:8355">Xenopus</span>
As the dually phosphorylated Phos-A peptide inhibits GSK3 phosphorylation of beta-catenin in vitro, we examined whether Phos-A could inhibit GSK3 and activate beta-catenin signaling in vivo. It has been well established that inhibition of GSK3, such as via a dominant-negative GSK3 mutant, activates Wnt/beta-catenin signaling and induces axis duplication in Xenopus embryos [46], [47], [48]. We found that injection of the Phos-A peptide, but not the A-mut peptide, in Xenopus embryos induced partial axis duplication and the expression of Xnr3, a direct downstream target gene for beta-catenin signaling [49] (Figure 6). Although the activity of the injected Phos-A peptide was significantly weaker compared to that of injected Xwnt8 mRNA (Figure 6), this was not unexpected since the phospho-peptide was likely subjected to dilution, proteolysis and/or dephosphorylation by proteases and/or phosphatases in the embryo in the absence of de novo synthesis. Importantly the A-mut peptide had no axis- or Xnr3-inducing activity in Xenopus embryos. These experiments demonstrate that the dually phosphorylated PPPSPXS peptide is able to activate Wnt/beta-catenin signaling in embryos, presumably via inhibition of GSK3 phosphorylation of beta-catenin in vivo.
###end p 33
###begin title 34
###xml 85 92 <span type="species:ncbi:8355">Xenopus</span>
The Phos-A but not the A-mut peptide induces axis duplication and Xnr3 expression in Xenopus embryos.
###end title 34
###begin p 35
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A, B, C, D</italic>
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 523 530 <span type="species:ncbi:8355">Xenopus</span>
A, B, C, D. Uninjected embryo (A), A-mut-injected embryo (B), and Phos-A-injected embryo (C) shown at neural fold stage. The duplicated partial axis is labeled by the red arrowhead. Ventrally injected Phos-A (4.8 ng/embryo) induced axis duplication in 19% embryos (10 of 52). A-mut (4.8 ng/embryo) did not induce axis duplication (0 of 60). Three independent experiments were combined (D). E. Phos-A (3 and 4.8 ng/embryo) but not A-mut (4.8 ng/embryo) induced Xnr3 expression in animal pole explants, as assayed by RT-PCR. Xenopus Wnt8 RNA injection (8 pg/embryo) served as a positive control. The activity of the Phos-A peptide was significantly weaker than that of Wnt8 RNA, likely due to dilution, proteolysis and/or dephosphorylation in the embryo in the absence of any de novo synthesis. WE: whole embryo. EF1-a: loading control. -RT: without reverse transcriptase.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 276 280 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 282 286 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 373 377 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 379 383 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Davidson1">[38]</xref>
###xml 482 486 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng3">[39]</xref>
###xml 488 492 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Bilic1">[40]</xref>
###xml 575 579 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 581 585 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 680 684 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Mao1">[36]</xref>
Although it is known that the activated Wnt/Frizzled/LRP6 receptor complex results in inhibition of beta-catenin degradation, the underlying molecular mechanism has remained unclear. One critical initiating event is Wnt-induced LRP6 phosphorylation at multiple PPPSPXS motifs [34], [35]. The phosphorylation of the PPPSPXS motif is sequentially carried out by GSK3 and CK1 [35], [38], and is under the control of the Frizzled receptor and its downstream partner Dishevelled protein [39], [40]. The dually phosphorylated PPPSPXS motif in turn provides a docking site for Axin [34], [35], thereby recruiting Axin and likely associated proteins to the Frizzled-LRP6 receptor complex [36]. But how these events lead to inhibition of beta-catenin phosphorylation by the Axin-GSK3 complex has been poorly understood.
###end p 37
###begin p 38
###xml 420 428 405 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g001">Figure 1</xref>
###xml 579 583 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 585 589 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 591 595 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 827 835 806 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g002">Figure 2</xref>
###xml 947 955 923 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3</xref>
###xml 1280 1288 1253 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g002">Figure 2</xref>
###xml 1413 1421 1383 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3</xref>
###xml 1656 1660 1623 1627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 1662 1666 1629 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 1668 1672 1635 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 1849 1857 1813 1821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3</xref>
###xml 2065 2069 2023 2027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 2118 2119 2076 2077 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 2133 2141 2091 2099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g002">Figure 2</xref>
###xml 2226 2234 2181 2189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g003">Figure 3</xref>
###xml 2356 2360 2308 2312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 2524 2525 2476 2477 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</underline>
###xml 2654 2658 2606 2610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 2820 2828 2769 2777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4</xref>
###xml 2994 2997 2940 2943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Liu1">[5]</xref>
###xml 2999 3003 2945 2949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Doble2">[50]</xref>
###xml 3231 3239 3174 3182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g006">Figure 6</xref>
###xml 563 570 <span type="species:ncbi:8355">Xenopus</span>
###xml 3120 3127 <span type="species:ncbi:8355">Xenopus</span>
We attempted to address this question via a beta-catenin phosphorylation assay reconstituted in vitro using recombinant beta-catenin, GSK3, CK1, and Axin. This in vitro system recapitulated key features of beta-catenin phosphorylation in vivo, such that GSK3 phosphorylation of beta-catenin at Ser33/Ser37/Thr41 is greatly enhanced by the presence of Axin and by priming phosphoryaltion of beta-catenin at Ser45 by CK1 (Figure 1). Given that a single PPPSPXS motif upon phosphorylation is sufficient to activate beta-catenin signaling in both mammalian cells and Xenopus embryos [34], [35], [37], we tested whether phosphorylated PPPSPXS motifs from LRP6 had any effect on beta-catenin phosphorylation in this in vitro assay. We found that each of four dually phosphorylated PPPSPXS peptides we examined, motifs A, C, D and E (Figure 2), exhibits inhibition of beta-catenin phosphorylation at Ser33/Ser37/Thr41 by GSK3 in a dose-dependent manner (Figure 3). We speculate that motif B may exhibit the same property, although we have not synthesized and tested a motif B peptide in our assay. Several aspects of this inhibition appear to correlate well with the properties of Wnt/LRP6 regulation of beta-catenin phosphorylation in vivo: (i) a corresponding mutant peptide, PPPAPXA (Figure 2), has little, if any, inhibitory effect on beta-catenin phosphorylation by GSK3 under the identical experimental condition (Figure 3). This correlates well with the fact that the dually phosphorylated PPPSPXS motif upon transferred to a heterologous receptor is sufficient to activate beta-catenin signaling in vivo, whereas the PPPAPXA mutant is completely inactive [34], [35], [37]. In addition, other control peptides including HA and 14-3-3BP (a dually phosphorylated peptide) do not have any inhibitory activity in the beta-catenin phosphorylation assay (Figure 3); (ii) the ability of dually phosphorylated PPPSPXS peptides to inhibit beta-catenin phosphorylation by GSK3 correlates well with their differential ability to activate beta-catenin signaling tested in vivo [37]. Thus the Phos-D peptide, which has an atypical CPPSPXS motif (Figure 2), has the weakest ability to inhibit beta-catenin phosphorylation by GSK3 in vitro (Figure 3) and also the least ability to activate beta-catenin signaling in vivo when it is transferred to a heterologous receptor [37]. Further, this result is also in line with that from scanning mutagenesis of the PPPSPXS motif, which has demonstrated a critical role of the first proline in the PPPSPXS motif such that its replacement by alanine or cysteine drastically diminished the signaling activity of the motif in vivo [37]; (iii) the dually phosphorylated PPPSPXS motif inhibits beta-catenin phosphorylation at Ser33/Ser37/Thr41 by GSK3 but not Ser45 phosphorylation by CK1 in vitro (Figure 4). This correlates with the fact that Wnt signaling primarily inhibits beta-catenin phosphorylation at Ser33/Ser37/Thr41 by GSK3 but not Ser45 phosphorylation by CK1 [5], [50]; (iv) finally we found that injection of a phosphorylated PPPSPXS peptide, but not the mutant PPPAPXA peptide, into Xenopus embryos is able to induce axis duplication and the expression of Xnr3, a Wnt/beta-catenin target gene (Figure 6), consistent with the notion that phosphorylated PPPSPXS inhibits GSK3 in vivo. These results together suggest that our in vitro observations with the PPPSPXS peptides likely reflect, at least in part, the function of these motifs in activated LRP6 in vivo.
###end p 38
###begin p 39
###xml 94 102 91 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g001">Figure 1</xref>
###xml 159 163 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 165 169 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 323 331 317 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4</xref>
###xml 613 621 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4</xref>
###xml 773 781 760 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4</xref>
###xml 813 855 800 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Mao1">[36; H. H. and X. H., unpublished results]</xref>
###xml 978 986 962 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4</xref>
###xml 1334 1337 1315 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Liu1">[5]</xref>
###xml 1437 1445 1415 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g004">Figure 4</xref>
Although Axin is required for beta-catenin phosphorylation by GSK3 both in vivo and in vitro (Figure 1), and Axin interacts with phosphorylated PPPSPXS motifs [34], [35], we were surprised to find that inhibition of GSK3 phosphorylation of beta-catenin by the phoshorylated PPPSPXS peptide is independent of Axin function (Figure 4). Two different Axin mutants, AxinDeltaDIX and Axin(351-701), are each fully capable of promoting beta-catenin phosphorylation by GSK3, and this phosphorylation is inhibited by the phosphorylated PPPSPXS peptide to the extent similar to that in the presence of the wild type Axin (Figure 4). Neither of these Axin mutants is expected to bind to the phosphorylated PPPSPXS motif because the DIX domain, which is deleted in both Axin mutants (Figure 4), is required for such binding [36; H. H. and X. H., unpublished results]. This point was best illustrated by Axin(351-701), which harbors only the GSK3- and beta-catenin-binding domains of Axin (Figure 4). These results led us to suspect that GSK3 is directly inhibited by the dually phosphorylated PPPSPXS peptide. Indeed, when a higher concentration of GSK3 is applied in vitro together with CK1 for priming phosphorylation, beta-catenin is phosphorylated at Ser33/Ser37/Thr41 (albeit less effectively) in the absence of Axin as previously reported [5], and this beta-catenin phosphorylation by GSK3 is inhibited by the phosphorylated PPPSPXS peptide (Figure 4), indicating a direct inhibition of GSK3 without the involvement of Axin.
###end p 39
###begin p 40
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 246 250 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Cselenyi1">[41]</xref>
###xml 395 399 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Cselenyi1">[41]</xref>
###xml 416 421 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 642 646 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 648 652 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 654 658 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 856 861 853 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 937 942 934 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1065 1070 1062 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1190 1194 1184 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Cselenyi1">[41]</xref>
###xml 1515 1523 1506 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g005">Figure 5</xref>
###xml 1775 1779 1763 1767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Mi1">[51]</xref>
###xml 138 145 <span type="species:ncbi:8355">Xenopus</span>
Cselenyi et al recently reported that the recombinant LRP6 intracellular domain directly inhibits GSK3 phosphorylation of beta-catenin in Xenopus egg extracts and in a reconstituted in vitro kinase assay similar to the one employed in this study [41]. They found that the inhibition of GSK3 by the LRP6 intracellular domain is direct and Axin-independent, and requires the intact PPPSPXS motifs [41]. While Cselenyi et al tested the LRP6 intracellular domain at a single concentration, our experiments examined each individual phosphorylated PPPSPXS motif, which represents the minimal signaling module as our previous studies have suggested [34], [35], [37], and we demonstrated dose-dependent inhibition of GSK3 by these phospho-PPPSPXS peptides at multiple concentrations. Overall our results are in good agreement with the main conclusions by Cselenyi et al. However, one noticeable difference exists between the results by Cselenyi et al and ours regarding the inherent (or the lack of) specificity of phospho-LRP6 inhibition of GSK3 phosphorylation. Cselenyi et al reported that the LRP6 intracellular domain specifically inhibits GSK3 phosphorylation of beta-catenin, but not of Tau [41]. By contrast, we found that the phosphorylated PPPSPXS peptide also inhibits GSK3 phosphorylation of Tau and glycogen synthase (GS, with priming phosphorylation by CK2), and indeed GSK3 phosphorylation of beta-catenin and Tau appears to be similarly inhibited by different concentrations of the phospho-PPPSPXS peptide (Figure 5). Our results suggest a general inhibition of GSK3 activity by the phosphorylated PPPSPXS peptide, and are consistent with an earlier study demonstrating that the LRP6 intracellular domain can inhibit GSK3 phosphorylation of both beta-catenin and Tau [51]. We note that our findings are fully compatible with specific inhibition of beta-catenin phosphorylation by Wnt signaling (see below).
###end p 40
###begin p 41
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Mi1">[51]</xref>
###xml 455 459 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 461 465 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Davidson1">[38]</xref>
###xml 740 744 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 760 764 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Mi1">[51]</xref>
###xml 832 836 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 838 842 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Mi1">[51]</xref>
###xml 907 911 901 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Mi1">[51]</xref>
###xml 1034 1038 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Bilic1">[40]</xref>
###xml 770 775 <span type="species:ncbi:4932">yeast</span>
One potential mechanism for the observed inhibition of GSK3 by the phosphorylated PPPSPXS peptide is substrate competition, given that the PPPSPXS motif is a substrate for GSK3 [35], [51], and may compete with beta-catenin for GSK3. However this mechanism does not easily explain why the phosphorylated PPPSPXS peptide has no inhibitory effect on beta-catenin phosphorylation at Ser45 by CK1, considering the fact that PPPSPXS is also a substrate for CK1 [35], [38]. Another potential mechanism, which is not mutually exclusive with the substrate competition model, is that the phosphorylated PPPSPXS motif may directly bind to GSK3 (but not CK1) and inhibit GSK3 kinase activity. Indeed GSK3 has been identified as an LRP6-binding protein [35] and vice versa [51] from yeast two-hybrid screens and can be co-precipitated with LRP6 [35], [51], and GSK3 associated with LRP6 exhibits reduced kinase activity [51]. We note that each LRP6 molecule has five phosphorylated PPPSPXS motifs and that LRP6 upon Wnt activation may multimerize [40]. Therefore a high local concentration of phosphorylated PPPSPXS motifs likely exists and their proximity to GSK3 via LRP6-Axin association may provide significant binding and inhibition to GSK3 in vivo even if the interaction between each phosphorylated PPPSPXS motif and GSK3 may not be particularly strong. We also note that the molar concentration of phospho-PPPSPXS peptides used in our GSK3 inhibition assays in vitro were at 0.4-, 1.5-, 6-, and 24-fold of that of GSK3, and that interestingly the phospho-peptides at 6-fold concentration relative to that of GSK3 exhibits significant inhibition towards GSK3, correlating remarkably with the five PPPSPXS motifs in each LRP6 protein. Therefore it seems that the relative concentrations of phospho-PPPSPXS peptides and GSK3 in our in vitro assays may be within a range conceivable in vivo.
###end p 41
###begin p 42
###xml 488 496 482 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g007">Figure 7</xref>
###xml 628 632 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 634 638 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 1497 1501 1488 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 1503 1507 1494 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Wolf1">[43]</xref>
###xml 2116 2120 2101 2105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Hendriksen1">[52]</xref>
In summary, we propose a working model to link LRP6 activation and the inhibition of beta-catenin phosphorylation. When activated by Wnt, PPPSPXS motifs in LRP6 intracellular domain are phosphorylated by GSK3 and CK1, and they act together to recruit Axin-GSK3 into the Wnt receptor complex. When Axin is bound to one of the phosphorylated PPPSPXS motifs, other phosphorylated PPPSPXS motifs in the vicinity of the Axin-GSK3 complex directly inhibit GSK3 phosphorylation of beta-catenin (Figure 7). Several considerations suggest the feasibility of this model. First, although each phosphorylated PPPSPXS motif can bind to Axin [34], [37], it is unlikely that these five PPPSPXS motifs clustered within a 120-residue region of LRP6 intracellular domain bind simultaneously to five molecules of Axin, which has 863 amino acids. Rather, these five PPPSPXS motifs together may provide a high local concentration of docking sites for a single Axin molecule, thereby ensuring a tight association between LRP6 and Axin. In this scenario multiple phosphorylated PPPSPXS motifs in each LRP6 are available for direct inhibition of GSK3. This model implies that the five PPPSPXS motifs when fully phosphorylated may have two major functions, i.e., to ensure the binding of Axin to LRP6 and to carry out inhibition of GSK3 phosphorylation of beta-catenin. This notion is consistent with the finding by others and us that the coorperativity of the five PPPSPXS motifs are critical for LRP6 signaling function [37], [43]. Secondly, this model explains LRP6 signaling specificity in the inhibition of beta-catenin phosphorylation, since GSK3 phosphorylation of other substrates such as GS and Tau occurs outside the Axin complex and is not in the proximity to LRP6 upon Wnt stimulation, and therefore will not be affected by the phosphorylated PPPSPXS motif under the physiological condition. Thirdly, direct inhibition of GSK3 by phospho-PPPSPXS motifs within LRP6 is consistent with a recent observation that upon Wnt stimulation dephosphorylated beta-catenin is observed at the plasma membrane together with the activated LRP6 [52].
###end p 42
###begin title 43
A working model for LRP6 inhibition of beta-catenin phosphorylation by the Axin-GSK3 complex.
###end title 43
###begin p 44
###xml 257 267 254 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Discussion</xref>
While one of the five phosphorylated PPPSPXS motifs of LRP6 physically interacts with Axin, other phosphorylated PPPSPXS motifs may directly inhibit GSK3 phosphorylation of beta-catenin in the Axin complex. Axin-binding to motif C is drawn arbitrarily. See Discussion for details.
###end p 44
###begin p 45
###xml 30 38 30 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004926-g007">Figure 7</xref>
###xml 343 347 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Liu3">[53]</xref>
###xml 665 669 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Kimelman1">[54]</xref>
We note that our above model (Figure 7) does not exclude the possibility that there also exist other mechanisms by which activated Wnt-Frizzled-LRP6 signaling leads to the inhibition of beta-catenin phosphorylation by GSK3. For example, dissociation of GSK3 from the Axin complex upon Wnt signaling has been suggested to be one such mechanism [53]. These parallel mechanisms may operate together to ensure prevention of GSK3 phosphorylation of beta-catenin upon Wnt stimulation. This may be analogous to parallel mechanisms that promote GSK3 phosphorylation of beta-catenin in the absence of Wnt stimulation, such as by GSK3 and CK1 phosphorylation of Axin and APC [54].
###end p 45
###begin p 46
###xml 370 374 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Piao1">[55]</xref>
While this manuscript was being revised for publication Piao et al reported that a dually phosphorylated PPPSPXS peptide (essentially identical to Phos-A in our study) inhibits GSK3 phosphorylation of both beta-catenin and Axin in vitro, and a LRP6 intracellular fragment containing a single PPPSPXS motif inhibits GS phosphorylation when overexpressed in the cytoplasm [55]. Consistent with our findings, Piao et al propose that phosphorylated PPPSPXS motif is a general inhibitor of GSK3 activity.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
Expression plasmids and baculoviruses
###end title 48
###begin p 49
###xml 80 84 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Liu2">[17]</xref>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
The pGEX4T1 vector expressing wild-type beta-catenin (GST-tagged) was described [17]. The mouse glycogen synthase C-terminal domain (mGS-CTD, amino acid 585-738) was cloned into the pGEX4T1 vector (GE Healthcare) using standard cloning procedures. pCS2+Axin, pCS2+AxinDeltaDIX, and pCS2+Axin(351-701) (all were Flag-tagged) were cloned using standard cloning procedures. The baculovirus expressing the Flag-tagged CK1 was a kind gift from Wade Harper (Harvard Medical School). Baculoviruses expressing 6xHis-tagged GSK3 and MBP-tagged Axin were kind gifts from Ethan Lee (Vanderbilt University).
###end p 49
###begin title 50
Protein expression and purification
###end title 50
###begin p 51
The GST-tagged beta-catenin and GST-tagged mGS-CTD were expressed by transforming expression plasmids into BL21 (DE3) cells, grown in LB Broth, and induced by 0.5 mM IPTG. Bacterial cells were then lysed by three cycles of freeze-thaw. The cell lysate was centrifuged at 14,000 rpm for 30 min, and the supernatant was incubated with glutathione agarose resin (Sigma). The bound proteins were washed by buffer and eluted by 7 mM glutathione. Baculoviruses for Flag-tagged CK1, His-tagged GSK3, and MBP-tagged Axin were amplified in the Sf9 insect cells (Invitrogen), and then used to infect the High-Five insect cells (Invitrogen), which were harvested two days after infection and lysed by freeze-thaw cycles. The M2 anti-Flag agarose resin (Sigma) was used to purify Flag-tagged CK1. The amylose resin (New England Biolab) was used to purify MBP-tagged Axin. The Ni-NTA agarose resin was used to purify His-tagged GSK3. The purified Tau protein was purchased from Calbiochem. Flag-Axin, Flag-AxinDeltaDIX, and Flag-Axin(351-701) were overexpressed by transfecting HEK293T cells with the respective expression plasmids, and purified using M2 anti-Flag agarose resin (Sigma) from cell extracts lysed in buffer with 0.5% NP40.
###end p 51
###begin title 52
Peptide synthesis
###end title 52
###begin p 53
###xml 570 574 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai2">[34]</xref>
###xml 576 580 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Zeng2">[35]</xref>
###xml 582 586 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-MacDonald1">[37]</xref>
###xml 797 798 793 794 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 876 877 872 873 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
The HA, 14-3-3BP, Phos-A, A-mut, Phos-C, Phos-D, and Phos-E peptides were synthesized by Tufts University Core Facility, purified by reverse phase HPLC, and their identities were confirmed by mass spectrometry. The synthesized peptides were dissolved in Tris buffer (pH 8.0) to 500 microM, and dialyzed by the 3,500 Dalton Molecular-Weight-Cut-Off Slide-A-Lyzer MINI dialysis units overnight to remove chemicals used in peptide synthesis. Recovery of peptides after dialysis was estimated to be 30% for all peptides using dot-blotting analysis via respective antibodies [34], [35], [37], with undialyzed peptides as standards. Phos-A and 14-3-3BP peptides were synthetically dually phosphorylated. Phos-C, Phos-D, and Phos-E peptides were synthesized as singly phosphorylated at the GSK3 site (PPPSPXS), and were further phosphorylated by CK1 at the second serine site (PPPSPXS) at 37degreesC for 3 hours in vitro.
###end p 53
###begin title 54
Mammalian cell transfection
###end title 54
###begin p 55
Transfections were done in HEK293T cells in 6-well plates using Fugene-6 (Roche). 48 hours after transfection, cells were lysed in a buffer containing 10 mM Tris (pH 8.0), 150 mM NaCl, 5 mM EDTA, 10 mM NaF, and 0.5% NP-40 with a cocktail of protease inhibitors. The cell lysates were centrifuged at 14,000 rpm for 10 minutes, and the supernatant of the cell lysates were taken for further studies.
###end p 55
###begin title 56
In vitro phosphorylation assay
###end title 56
###begin p 57
###xml 123 124 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The phosphorylation assays were performed in buffer containing: 25 mM Hepes pH 7.5, 20 mM beta-glycerophosphate, 25 mM MgCl2, 2 mM DTT, and 10 mM ATP (pH 7.0), in a total volume of 15 microl at 37degreesC for 3 hours. For Axin-dependent phosphorylation of beta-catenin, 0.43 microM of GSK3, 0.54 microM of CK1alpha, 0.21 microM of Axin, and 0.73 microM of beta-catenin were used in each assay. For Axin-independent phosphorylation of beta-catenin, the condition was the same except that 2.2 microM of GSK3 (and no Axin) were used in each assay. For phospho-peptide (or control peptide) inhibition experiments, 1 microl of the dialyzed peptide (final concentration: 10 microM) or four-fold serially diluted peptide (final concentrations: 2.5 microM, 0.63 microM, and 0.16 microM) was used in each assay. For GS phosphorylation, 0.50 microM of CK2 proteins, 0.43 microM of GSK3, and 0.8 microM of GST-mGS-CTD were used in each reaction. For Tau phosphorylation, 0.43 microM of GSK3 and 0.8 microM of Tau protein were used in each reaction. Each in vitro assay was repeated three or more times.
###end p 57
###begin title 58
Antibodies and western blotting
###end title 58
###begin p 59
###xml 427 438 <span type="species:ncbi:3704">horseradish</span>
The supernatant of cell lysates or kinase reaction products were examined by SDS-PAGE, and analyzed by Western blotting using Immobilon-P membrane (Millipore). The membranes were incubated in blocking buffer (5% nonfat dry milk in TBS buffer with 0.1% Tween-20) for 1 hour at room temperature, and then were incubated with primary antibodies diluted in 1% BSA in the TBS/Tween-20 buffer for 1 hour, followed by incubation with horseradish peroxide-conjugated secondary antibodies diluted at 1:10,000 in 1% BSA in the TBS/Tween-20 buffer for 30 minutes. Protein detection was performed using the ECL system (Amersham Pharmacia). The following antibodies were used (values in parentheses are the dilution ratios used for Western blotting): anti-phospho-Ser33/Ser37/Thr41 beta-catenin (1:1000) from Cell Signaling (9561S); anti-phospho-Ser45 beta-catenin (1:1000) from Cell Signaling (9564S); anti-beta-catenin (1:1000) from BD Biosciences (610153); anti-phospho-Ser641 glycogen synthase (1:1000) from Cell Signaling (3891S); and anti-Tau (1:1000) from Cell Signaling (4019). The PHF1 anti-phosphor-Tau antibody was a kind gift from Peter Davies (Albert Einstein School of Medicine).
###end p 59
###begin title 60
###xml 0 7 <span type="species:ncbi:8355">Xenopus</span>
Xenopus embryos
###end title 60
###begin p 61
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004926-Tamai1">[30]</xref>
Embryo manipulations and RT-PCR were described previously [30]. Embryos were injected with the Phos-A or A-mutant peptide in the ventral marginal region at 8-cell stage for the axis-duplication assay, or in the animal region at 4-cell stage for the animal pole explant assay.
###end p 61
###begin p 62
The author thanks Bryan MacDonald and other He lab members for discussions and suggestions. We acknowledge generous reagents from Drs. Ethan Lee, Travor Dale, Wade Harper, and Peter Davies.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
The Wnt signaling pathway in development and disease Annu.
###end article-title 64
###begin article-title 65
The promise and perils of Wnt signaling through beta-catenin.
###end article-title 65
###begin article-title 66
You Wnt some, you lose some: oncogenes in the Wnt signaling pathway.
###end article-title 66
###begin article-title 67
Wnt signaling and cancer.
###end article-title 67
###begin article-title 68
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.
###end article-title 68
###begin article-title 69
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation.
###end article-title 69
###begin article-title 70
Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.
###end article-title 70
###begin article-title 71
###xml 34 39 <span type="species:ncbi:9606">human</span>
Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.
###end article-title 71
###begin article-title 72
Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3 and beta-catenin and promotes GSK-3-dependent phosphorylation of beta-catenin.
###end article-title 72
###begin article-title 73
Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
###end article-title 73
###begin article-title 74
###xml 22 29 <span type="species:ncbi:8355">Xenopus</span>
Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin.
###end article-title 74
###begin article-title 75
###xml 97 104 <span type="species:ncbi:8355">Xenopus</span>
Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts.
###end article-title 75
###begin article-title 76
Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.
###end article-title 76
###begin article-title 77
###xml 84 94 <span type="species:ncbi:7227">Drosophila</span>
Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila.
###end article-title 77
###begin article-title 78
Threonine 41 in beta-catenin serves as a key phosphorylation relay residue in beta-catenin degradation.
###end article-title 78
###begin article-title 79
The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.
###end article-title 79
###begin article-title 80
###xml 73 80 <span type="species:ncbi:8355">Xenopus</span>
beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation.
###end article-title 80
###begin article-title 81
The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.
###end article-title 81
###begin article-title 82
An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin.
###end article-title 82
###begin article-title 83
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin.
###end article-title 83
###begin article-title 84
Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase.
###end article-title 84
###begin article-title 85
Ozz; a new name on the long list of beta-catenin's nemeses.
###end article-title 85
###begin article-title 86
beta-catenin is a target for the ubiquitin-proteasome pathway.
###end article-title 86
###begin article-title 87
Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin.
###end article-title 87
###begin article-title 88
Functional interaction of beta-catenin with the transcription factor LEF-1.
###end article-title 88
###begin article-title 89
Nuclear localization of beta-catenin by interaction with transcription factor LEF-1.
###end article-title 89
###begin article-title 90
###xml 76 83 <span type="species:ncbi:8355">Xenopus</span>
XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos.
###end article-title 90
###begin article-title 91
Identification of c-MYC as a target of the APC pathway.
###end article-title 91
###begin article-title 92
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
###end article-title 92
###begin article-title 93
LDL-receptor-related proteins in Wnt signal transduction.
###end article-title 93
###begin article-title 94
arrow encodes an LDL-receptor-related protein essential for Wingless signalling.
###end article-title 94
###begin article-title 95
###xml 59 63 <span type="species:ncbi:10090">mice</span>
An LDL-receptor-related protein mediates Wnt signalling in mice.
###end article-title 95
###begin article-title 96
LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way.
###end article-title 96
###begin article-title 97
A mechanism for Wnt coreceptor activation.
###end article-title 97
###begin article-title 98
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation.
###end article-title 98
###begin article-title 99
Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway.
###end article-title 99
###begin article-title 100
Wnt signal amplification: activity, cooperativity and regulation of multiple intracellular PPPSP motifs in the Wnt coreceptor LRP6.
###end article-title 100
###begin article-title 101
Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction.
###end article-title 101
###begin article-title 102
Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions.
###end article-title 102
###begin article-title 103
Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation.
###end article-title 103
###begin article-title 104
LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin.
###end article-title 104
###begin article-title 105
Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex.
###end article-title 105
###begin article-title 106
Multiple PPPS/TP motifs act in a combinatorial fashion to transduce Wnt signaling through LRP6.
###end article-title 106
###begin article-title 107
GSK-3: tricks of the trade for a multi-tasking kinase.
###end article-title 107
###begin article-title 108
Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau.
###end article-title 108
###begin article-title 109
###xml 58 65 <span type="species:ncbi:8355">Xenopus</span>
Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos.
###end article-title 109
###begin article-title 110
###xml 98 105 <span type="species:ncbi:8355">Xenopus</span>
Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos.
###end article-title 110
###begin article-title 111
Regulation of Spemann organizer formation by the intracellular kinase Xgsk-3.
###end article-title 111
###begin article-title 112
Formation and function of Spemann's organizer.
###end article-title 112
###begin article-title 113
Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines.
###end article-title 113
###begin article-title 114
The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity.
###end article-title 114
###begin article-title 115
Plasma membrane recruitment of dephosphorylated beta-catenin upon activation of the Wnt pathway.
###end article-title 115
###begin article-title 116
Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins.
###end article-title 116
###begin article-title 117
beta-catenin destruction complex: insights and questions from a structural perspective.
###end article-title 117
###begin article-title 118
Direct inhibition of GSK3beta by the phosphorylated cytoplasmic domain of LRP6 in Wnt/beta-catenin signaling.
###end article-title 118
###begin p 119
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 119
###begin p 120
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a Leukemia and Lymphoma Society Special Fellowship to G. W, and by NIH RO1-GM74241 to X. H, who is a Leukemia and Lymphoma Society Scholar. HH is supported by a postdoctoral fellowship from CIHR (Canadian Institute of Health Research). JGA is a visiting professor and in part supported by a Brazilian Scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 120

